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Abstract
Background: An available whole genome sequence for Aspergillus flavus provides the opportunity to characterize factors
involved in pathogenicity and to elucidate the regulatory networks involved in aflatoxin biosynthesis. Functional analysis
of genes within the genome is greatly facilitated by the ability to disrupt or mis-express target genes and then evaluate
their result on the phenotype of the fungus. Large-scale functional analysis requires an efficient genetic transformation
system and the ability to readily select transformants with altered expression, and usually requires generation of double
(or multi) gene deletion strains or the use of prototrophic strains. However, dominant selectable markers, an efficient
transformation system and an efficient screening system for transformants in A. flavus are absent.
Results: The efficiency of the genetic transformation system for A. flavus based on uracil auxotrophy was improved. In
addition, A. flavus was shown to be sensitive to the antibiotic, phleomycin. Transformation of A. flavus with the ble gene
for resistance to phleomycin resulted in stable transformants when selected on 100 µg/ml phleomycin. We also
compared the phleomycin system with one based on complementation for uracil auxotrophy which was confirmed by
uracil and 5-fluoroorotic acid selection and via transformation with the pyr4 gene from Neurospora crassa and pyrG gene
from A. nidulans in A. flavus NRRL 3357. A transformation protocol using pyr4 as a selectable marker resulted in site
specific disruption of a target gene. A rapid and convenient colony PCR method for screening genetically altered
transformants was also developed in this study.
Conclusion: We employed phleomycin resistance as a new positive selectable marker for genetic transformation of A.
flavus. The experiments outlined herein constitute the first report of the use of the antibiotic phleomycin for
transformation of A. flavus. Further, we demonstrated that this transformation protocol could be used for directed gene
disruption in A. flavus. The significance of this is twofold. First, it allows strains to be transformed without having to
generate an auxotrophic mutation, which is time consuming and may result in undesirable mutations. Second, this
protocol allows for double gene knockouts when used in conjunction with existing strains with auxotrophic mutations.
To further facilitate functional analysis in this strain we developed a colony PCR-based method that is a rapid and 
convenient method for screening genetically altered transformants. This work will be of interest to those working on 
molecular biology of aflatoxin metabolism in A. flavus, especially for functional analysis using gene deletion and gene 
expression.
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Background
Aspergillus flavus is a ubiquitous fungus and a plant and
animal health concern. It can colonize seeds of maize,
peanuts, cotton, and tree nuts during development and
contaminate them with the carcinogenic secondary
metabolite, aflatoxin (AF), which affects food safety and
agricultural trade [1]. A. flavus is also the second leading
cause of aspergillosis in humans and the leading causative
agent of chronic indolent invasive sinonasal infection in
immunocompetent patients [2].
Due to the significant health and economic impacts of AF
contamination, much attention has been paid to the bio-
chemistry, genetics, and molecular biology of the AF bio-
synthetic pathway [3]. The genes encoding the
biosynthetic pathway are clustered in a 70 kb region of the
chromosome [4]. Many factors, such as nutrition, pH,
temperature, exogenous stress, and fungal development
have been observed to affect AF production [5,6]. How-
ever, it still remains unclear how these factors influence AF
production and how regulatory elements such as the afla-
toxin pathway transcription factor aflR are controlled.
An available genome sequence of this fungus holds prom-
ise in addressing important questions concerning patho-
genicity and the regulatory elements involved in AF
biosynthesis. Future studies will require an efficient and
reproducible A. flavus transformation system. A successful
transformation system relies on effective selectable mark-
ers, a highly efficient and reproducible transformation
procedure, and a rapid and reliable screening procedure
for transformants. The most commonly used method to
select for genetic transformants in Aspergillus species uti-
lizes auxotroph complementation. While such selection
can be effective, it requires that the recipient strain be
mutated for auxotrophy [7] and it is difficult to generate a
double mutant strain for genomic analysis.
Marker genes encoding resistance to antibiotics have been
used in genetic engineering and molecular biology
research in various organisms [8,9]. Unfortunately, A. fla-
vus and many other species of Aspergillus  are relatively
resistant to these antibiotics, rendering them unusable as
selectable markers. The antibiotic phleomycin has now
been widely applied in transformation of plant and ani-
mal cells, and fungi [8,10-13]. However, there is no
report, to date, utilizing this antibiotic for A. flavus trans-
formation. We described here the use of phleomycin
resistance combined with uracil auxotrophy for A. flavus
transformation. This technology allows the creation of
double mutant strains and the transformation of pro-
totrophic strains of A. flavus.
Gene disruption and overexpression play central roles in
the analysis of gene function related to aflatoxin biosyn-
thesis. Homologous recombination is, in principle, the
most efficient method of disrupting or replacing a target
gene. However, deletion of many genes is not expected to
result in a readily detectable phenotype, and no data on
the frequency of gene replacement in most organisms
(including A. flavus) is available. Establishing a simple
and reliable method for screening transformants is impor-
tant for detecting transformants which have the correct
gene deletion/replacement from within a large pool of
transformants. PCR (Polymerase Chain Reaction) is
among the assays that have been applied to the rapid
screening of transgenes. DNA extraction is usually the
most time-consuming requirement of this process and
this can hinder its effective deployment when either a
large number of samples need to be analyzed or when
there is only a small amount of material for DNA extrac-
tion [14]. DNA extraction protocols for fungi [15,16] are
inefficient in releasing the cellular contents from mature
hyphae or spores. We report a rapid PCR-based screening
method for identifying transformants of A. flavus.
Results
Sensitivity of A. flavus to antibiotics
The resistance of A. flavus 3357 to kanamycin (Sigma) and
hygromycin (Sigma) was tested because they have been
used widely in other systems and are relatively inexpen-
sive. Spores of A. flavus 3357 (105 spores/plate) were inoc-
ulated onto MM plates (Czapek Dox medium)
supplemented with kanamycin at 100, 500, and 1000 µg/
ml, or hygromycin at 500, 1000, and 1500 µg/ml. No sen-
sitivity to either antibiotic was detected at any of the tested
concentrations. Similarly, growth of A. flavus spores (105
or 107 per plate) was not inhibited on YPD medium sup-
plemented with either 70 or 100 µg/ml of nourseothricin.
In contrast, growth of A. flavus was inhibited on MM
medium amended with 50 µg/ml or 100 µg/ml phleomy-
cin. Medium pH affected the activity of phleomycin. No
growth was detected at either concentration of phleomy-
cin when the pH of the medium was 7.5; however, inhibi-
tion of growth was inconsistent on medium at pH 6.5.
Phleomycin as a selection marker in A. flavus 
transformation
To examine the potential for phleomycin as a selectable
marker for transformants of A. flavus, strain 3357 was
transformed with pBC-phleo, a construct containing the
ble gene for phleomycin resistance controlled by the A.
nidulans gpdA promoter and the S. cerevisiae CYC1 termi-
nator [17]. Transformants were clearly visible on phleo-
mycin-containing MLS medium after 2 days of incubation
at 37°C. Selection of stable transformants was enhanced
at pH 7.5 as compared to pH 6.5. A few colonies were
found on the no-DNA transformation control plates
when the protoplasts were plated onto MLS medium con-
taining 100 µg/ml of phleomycin at pH 6.5. In contrast,BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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no growth was observed in the control plates at either 50
or 100 µg/ml of phleomycin when the pH was adjusted to
pH 7.5
The concentration of phleomycin in the regeneration
medium also affected the selection of stable transform-
ants. Twice as many colonies were observed when trans-
formants carrying pBC-phleo were plated on MLS plus 50
µg/ml of phleomycin versus 100 µg/ml (Figure 1). To
determine the stability of these transformants, 50 colonies
from media amended with each phleomycin concentra-
tion were plated first on non-selective PDA medium (pH
7.5) and then later transferred to both PDA (pH 7.5) and
PDA (pH 7.5) supplemented with 100 µg/ml of phleomy-
cin. Only those transformants that grew equally well on
PDA plus phleomycin as on PDA were considered stable
transformants. After three transfers, only 1 of 34 colonies
from the original plate selected on 50 µg/ml of phleomy-
cin maintained resistance to phleomycin. Conversely, 11
of 18 colonies selected on 100 µg/ml of phleomycin
remained phleomycin-resistant after subculturing. Thus
both 50 µg/ml phleomycin and 100 µg/ml were inhibi-
tory to fungal growth, but more stable transformants were
obtained using 100 µg/ml of phleomycin. When 100 µg/
ml of phleomycin was used for selection, we were able to
consistently obtain transformants with a single integra-
tion of the ble gene as shown by Southern analysis (Figure
2).
Isolation of pyrG mutants of A. flavus NRRL 3357
No uracil auxotroph of A. flavus strain NRRL 3357 is avail-
able. Because the genome sequence is complete for this
strain, the selection of a uracil mutant will allow genetic
transformation of this strain by established protocols and
facilitate studies on its pathogenicity and toxin produc-
tion. A. flavus NRRL 3357 (105 or 107 spores) was inocu-
lated onto plates containing MM medium (2% agar)
supplemented with 5-fluoroorotic acid (FOA) at 0, 0.5,
1.0, 1.5, or 2.0 mg/ml. No growth was observed on any
plates containing FOA. Conidia of A. flavus 3357 were
subjected to NQO mutagenesis and incubated on MMU
Southern blot analysis showing the presence of the pBC- phleo vector in two transformants of Aspergillus flavus Figure 2
Southern blot analysis showing the presence of the 
pBC-phleo vector in two transformants of Aspergillus 
flavus. Lanes 1 and 5: strain 3357-5; lanes 2 and 6: strain 
3357-5 transformed with a pBC-phleo alcA::rasA construct: 
Lanes 3 and 7: strain 3357-5 ∆rdiA complemented with the 
pBC-phleo vector containing rdiA. Lane 4: Blank. DNA in 
lanes 1–3 digested with BamH I and DNA in lanes 5–7 
digested with Kpn I. Southern hybridization was performed 
using a probe amplified from plasmid pBC-phleo with the fol-
lowing primer pairs: BleF, 5'CCCGCTTGAGCAGACATC3' 
and BleR, 5'TCGTCCTGACTGGCTGCG3'.
Transformants of A. flavus 3357 with pBC-phleo Figure 1
Transformants of A. flavus 3357 with pBC-phleo. Twice as many colonies were observed when transformants were 
plated on MLS plus 50 µg/ml of phleomycin (left 2 plates) versus 100 µg/ml of phleomycin (right 2 plates). The two plates lack-
ing growth of the fungus are negative controls for untransformed A. flavus 3357 under the selection of phleomycin at 50 µg/ml 
(left) or 100 µg/ml (right).BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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containing 1.5 or 2.0 mg/ml of FOA at 30°C for one week.
A total of 110 colonies were randomly selected from both
FOA-containing media. The colonies were cultured on
either MMU or MM simultaneously for three generations,
and then transferred to four different media (MM, MMU,
MM + 2 mg/ml FOA, and MMU + 2 mg/ml FOA) to con-
firm and identify pyrG  mutants. Six colonies originally
selected on 1.5 mg/ml FOA grew on all four media, indi-
cating they were FOA resistant mutants but not uracil aux-
otrophs. In contrast eight colonies originally selected on
medium contained 2.0 mg/ml FOA grew on MMU and
MMU plus FOA but not on MM and MM plus FOA, indi-
cating they were FOA resistant mutants and uracil auxo-
trophs.
Thin layer chromatography (TLC) analysis confirmed that
eight colonies selected still possessed the ability to pro-
duce aflatoxin (see Figure 3). The ability of the pyrG
mutant to produce aflatoxin is essential for studies
designed to examine aflatoxin biosynthesis. Mutant colo-
nies #3, #5, and #7 were randomly chosen for quantifica-
tion of AF production using HPLC. These three strains
produced aflatoxin concentrations comparable to the
original strain 3357 (Table 1). The mutants were desig-
nated A. flavus strains 3357-3, 3357-5, and 3357-7.
Transformation of mutant 3357-5 with the heterologous
pyr4 gene from Neurospora crassa and pyrG gene from A.
nidulans was performed to further confirm this putative
pyrG mutant. Transformants of either the pyr4 gene or pyrG
gene exhibited a uracil-prototrophic phenotype, which
appeared to be stable for more than 10 generations. Com-
parison of this strain with the original strain 3357 showed
that there were no phenotypic differences when cultured
at different temperatures (16°C, 28°C, 37°C, or 42°C) or
at different pHs (4.0, 6.0, and 8.0). However, the growth
of mutant 3357-5 was a little slower than the wild-type
3357 when cultured on PDA supplemented with only
uracil. The growth of the mutant is improved when the
medium is supplemented with both uracil and uridine
(Figure 4).
Strain 3357-5 was also used for transformation using the
phleomycin marker (Figure 2). A gene knockout for a rho-
dissociation inhibitor was created in 3357-5 by use of the
pyr4 gene to complement uracil auxotrophy; this strain
was then complemented with the native gene using the
pBC-phleo vector. In another transformation using the ble
gene, strain 3357-5 was transformed with a plasmid
designed for overexpression of a GTPase while retaining
the pyrG mutation.
Factors affecting transformation of A. flavus
We evaluated factors responsible for efficient transforma-
tion of A. flavus through introduction of circular and lin-
ear DNA into A. flavus strain 3357-5. Cell wall lysis and
protoplasting were accomplished using the mixture of
enzymes as described in the Methods section. We found
that the composition of the digestion buffer influenced
the number of transformants obtained from the transfor-
Visualization of aflatoxin production in strain 3357 and the generated pyrG mutants of 3357 by thin layer chromatography  (TLC) Figure 3
Visualization of aflatoxin production in strain 3357 and the generated pyrG mutants of 3357 by thin layer chro-
matography (TLC). B1: standard for aflatoxin B1 (Sigma). B2: standard for aflatoxin B2 (Sigma). Lanes labeled #1-#8 repre-
sent pyrG mutants. 3357: original A. flavus strain.BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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mation protocol. A buffer consisting of 7% NaCl, 10 mM
NaPO3, and 2.5 mg/ml BSA produced protoplasts which
gave a transformation efficiency of 200–300 colonies per
µg of pBSK-pyr4 DNA. The addition of BSA to the enzyme
solution greatly increased transformation efficiency in
this system (data not shown).
Using this protocol we found two types of transformants
after 2–4 d of incubation on MLS at 37°C. Type 1 colonies
(about 10% of the total) grew fast and sporulated nor-
mally. The majority of transformants were type 2 colonies,
which failed to grow past the initial growth observed after
24 or 36 h of incubation, and almost none sporulated. To
determine whether these two types were stable transform-
ants, individual colonies were picked onto PDAU and
incubated for 2–3 d at 30°C. The picked transformants
were then transferred to both PDAU and PDA medium,
grown for an additional 2–3 d, and serially transferred
from PDAU to both PDAU and PDA for 4–5 iterations.
More than 90% of the type 1 colonies remained pro-
totrophic for uracil after the serial transfers while only 3%
of the type 2 colonies were prototrophs. In an attempt to
increase the number of stable type 2 colonies, the follow-
ing regeneration media were examined: 1.2 M sorbitol;
0.6 M sorbitol; 0.4 M (NH4)2SO4  (MLS); 0.4 M
(NH4)2SO4 (MLS, pH to 7.5); 0.2 M (NH4)2SO4; 0.6 M
KCl; 0.4 M KCl; 1 M sucrose; and 0.6 M sucrose. None of
these media improved the stability of the type 2 trans-
formants. Interestingly, we found similar stable transfor-
mation frequencies when either the pyr4 or the pyrG gene
was used to complement the uracil mutation; however, no
type 2 colonies were observed in the transformation using
pyrG for complementation.
Co-transformation of pyr4 and ble genes and comparison 
of transformation frequency between these two genes
Co-transformation of A. flavus strain 3357-5 with 1 µg
pBSK-pyr4 and 1 µg pBC-phleo was performed using MLS
regeneration medium (pH7.5) supplemented with either
100 µg/ml phleomycin plus uracil, or 100 µg/ml phleo-
mycin only, or neither phleomycin nor uracil. After 3 d of
incubation, 75, 9, and 3 colonies were obtained on MLS +
phleomycin + uracil (for ble  selection), MLS (for pyrG
selection), and MLS + phleomycin (for co-transformation
selection) respectively. We observed that the transforma-
tion frequency (stable transformants per µg plasmid) dif-
fered between pBSK-pyr4 and pBC-phleo. The
transformation frequency of pBC-phleo is much higher
than pBSK-pyr4 upon co-transformation and when trans-
formed separately.
Colony PCR analysis to identify a gene knockout strain
A gene predicted to be a superoxide dismutase (GenBank
No: CA747446) was deleted in A. flavus 3357-5 using an
overlap PCR technique [18] (Figure 5). Various genomic
DNA extraction procedures that included using germi-
nated conidia, heating conidia in a microwave oven,
digesting conidia via an enzyme cocktail (lysing enzyme,
driselase, β-glucorinidase), treating conidia with SDS plus
phenol, or CTAB were attempted. PCR was performed to
identify deletion mutants following selection on uracil-
deficient medium. We found the CTAB DNA extraction
method to be efficient and to yield repeatable results. Fig-
Growth comparison of A. flavus 3357 and pyrG mutant 3357- 5 on either PDA, PDAU or PDAUU Figure 4
Growth comparison of A. flavus 3357 and pyrG 
mutant 3357-5 on either PDA, PDAU or PDAUU. U: 
uracil; UU: uracil plus uradine.
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Table 1: Aflatoxin analysis by high performance liquid chromatography (HPLC) for selected A. flavus pyrG mutants
Aflatoxin, ng/ml
Strain pH * G2 G1 B2 B1 Total
A. flavus 3357 5.47 0 0 1172.7 23009.0 24182.7
A. flavus 3357-3 5.30 0 0 1167.9 29618.2 30786.1
A. flavus 3357-5 5.10 0 0 1109.5 21296.2 22405.7
A. flavus 3357-7 5.58 0 0 1215.7 34758.7 35974.4
* The pH value of the medium was measured after culturing for 36 h.BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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ure 6 shows the results of colony PCR from genomic DNA
extracted using the CTAB method, using the primer pairs
P1 and P6 to identify the transformants. A PCR product of
2679 bp in length identifies the native locus (see lanes 1,
4, 5, 6, 11, and 14 in Figure 6). Alternatively, a PCR prod-
uct of 3385 bp in length identifies gene replacement by
the pyr4 marker gene (Figure 6 lanes 3, 12, 13, and 17).
The presence of PCR products of 3385 bp and 2679 bp in
length indicates that the gene deletion construct inserted
ectopically in the A. flavus genome (Figure 6 lanes 7, 8, 9,
10, 15, 16, 18, 19, and 20). To further confirm if the target
sequence was replaced by pyr4, another set of PCR was
Colony PCR products for identifying uracil-independent transformants using genomic DNA extracted by CTAB method and  primer pairs P1 and P6 Figure 6
Colony PCR products for identifying uracil-independent transformants using genomic DNA extracted by 
CTAB method and primer pairs P1 and P6. Lane 1: The control native target sequence which PCR-amplified from 3357-
5; Lane 3–20: From different transformant colonies.
Overlap PCR construct for transformation of A. flavus and the location of primers for identifying transformants using PCR- based screen Figure 5
Overlap PCR construct for transformation of A. flavus and the location of primers for identifying transformants 
using PCR-based screen. Primers P2, P3, P4, and P5 consist of two parts, one part is homologous to the putative superox-
ide dismutase (P-SOD) gene (GenBank accession no: CA747446) and another part is homologous to selection marker pyr4.BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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performed for selected knockout mutants SOD#5 (lane 3
in Figure 6) and SOD#30 (lane 12 in Figure 6) using
primer pairs P0 and P5, P0 and P6, and P1 and P6 (Figure
7). We found that the target sequences in these 2 knock-
out mutants were exactly replaced by the gene deletion
construct through homologous recombination. Further
Southern blot analysis confirmed that there is only one
copy of pyr4 in the genome of SOD#5 strain and that
strain SOD#30 may have one or more ectopic copies in
addition to the site directed integration (Figure 8).
Discussion
We developed a new transformation protocol for A. flavus
based on phleomycin resistance. To our knowledge this is
the first report of phleomycin being used as a marker for
A. flavus transformations. One factor important for the
success of this procedure is the pH of the regeneration
medium containing phleomycin. We found A. flavus to be
the most sensitive to phleomycin at pH 7.5. Interestingly,
this pH differs from the optimum pH for selection of N.
crassa transformants. Austin et al. [10] found pH 5.3–5.8
to give the best selection of N. crassa transformants. Also
important for the selection of stable transformants using
this marker is the concentration of phleomycin in the
regeneration medium. While phleomycin at 50 µg/ml
resulted in more apparent transformants, they did not
maintain stable resistance upon subculturing. We found
that regeneration of transformed protoplasts on medium
containing 100 µg/ml phleomycin to result in a higher
percentage of stable transformants.
Other commonly used chemicals for selection of trans-
formants were examined in our study. Neither hygromy-
cin, kanamycin, nor nourseothricin were found to be toxic
to the fungus. Our results on the toxicity of hygromycin
differ from those of Ramesh et al. who reported the dis-
ruption of the serine proteinase gene (sep) in A. flavus
using the hygromycin resistance gene as a selectable
marker [19]. This discrepancy may reflect a genetic differ-
ence between the two strains examined.
The ability to use phleomycin in a tranformation protocol
for NRRL 3357 allows a researcher to avoid using the com-
plementation of an auxotrophic mutation for selection of
transformations, which is currently the most commonly
used procedure for the Aspergilli. This is important for two
reasons. First, the generation of auxotrophic mutants
often requires a mutagenic agent, which may result in
other changes in the strain that may not be readily appar-
ent. Second, auxotrophic strains can be problematic when
used in pathogenicity studies. This second point is partic-
ularly true if it is desirable to characterize the function of
a gene by first doing a gene deletion and then adding a
functional gene back in the same strain. Such a compari-
son would require two auxotrophic mutations, one of
which would not be complemented in the gene deletion
mutant. The presence of the nutritional mutation may
compromise the growth of the gene deletion strain on nat-
ural substrates that cannot be supplemented with the nec-
essary nutrient. We demonstrated in this study that
phleomycin selection can be used to complement the
function of a gene previously deleted in the same strain by
a DNA deletion construct containing pyr4.
The transformation efficiency differed among the two
selectable markers. A percentage of the pyr4 transformants
formed tiny abortive type 2 colonies, which was reported
before in our laboratory [20]. This phenomenon also has
been observed in transformation of A. nidulans with the
heterologous A. nidulans trpC gene [21] and N. crassa pyr4
gene [22]. In contrast, fewer of the ble and the pyrG trans-
formants formed type 2 colonies.
In this study also we provide an improved protocol for
genetic transformation of A. flavus. Regardless of the selec-
tive marker, an efficient transformation protocol remains
critical to functional analysis. Several conditions were
examined in the existing protocol developed in this lab
[20]. The most significant increase in transformation
resulted from the addition of BSA to the digestive mixture
used to release the protoplasts. The addition of BSA in
digestion mixture has been used for protoplast isolation
of Tuber borchii, Aspergillus sp., and Penicillium brevicompac-
tum [23,24]. The effect of BSA is not always positive, and
thus its effect may be species specific. We found the addi-
tion of BSA in the protoplast-generating buffer to be criti-
PCR-amplification of 2 uracil-independent transformants  SOD#5 and SOD#30 using different primer pairs to confirm  if the transformation construct replaced the target sequence Figure 7
PCR-amplification of 2 uracil-independent trans-
formants SOD#5 and SOD#30 using different primer 
pairs to confirm if the transformation construct 
replaced the target sequence. Lane 2–4: template DNA 
from transformant SOD#5 (Lane 3 in Figure 6), Lane 5–7: 
template DNA from transformant SOD#30 (lane 12 in Fig-
ure 6). Primer pairs used as: P1 and P6 were used on lane 2 
and 5, band size is 3385 bp; Primers P0 and P6 were used on 
lane 3 and 6, band size is 3385 + 101 = 3486 bp; Primers P0 
and P5 were used on lane 4 and 7, band size is 3385 + 101 -- 
1005 = 2481 bp.BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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cal for increasing the transformation efficiency of A. flavus.
The positive effect of BSA is unknown, but may be related
to the overall quality of the protoplasts from A. flavus. The
changes made in the protocol consistently improved
transformation efficiency of A. flavus. Both circular plas-
mid and linear PCR products were transformed into A. fla-
vus with high frequency. We could also easily obtain co-
transformants of plasmids containing the phleomycin-
resistance marker and plasmids containing the pyr4
marker, which provides a powerful tool for the introduc-
tion of any non-selectable genetic material into A. flavus.
We further tested A. flavus strain 3357-5 to see if it could
be used for gene disruption experiments. We generated a
pyr4-containing disruption construct of a putative super-
oxide dismutase gene and used it to transform strain
3357-5. We obtained several transformants and character-
ized them by PCR. The results from PCR (Figure 6)
showed that many of the transformants contained the full
length knockout construct. A large percentage of these
also contained the native gene indicating ectopic integra-
tion. This result is similar to what we have obtained with
other knockout constructs. In order to further test for gene
disruption, we performed a southern analysis. We chose
two transformants, SOD#5 and SOD#30, based on the
number of bands generated by PCR. We used a full length
pyr4 probe to test for multiple integration events. Consist-
ent with a single site directed integration event, we
observed one band with SOD#5. Two bands were
observed with SOD#30 indicating one or more ectopic
integrations (Figure 8).
Another important consideration for high throughput
functional genomics is the selection of transformants
because the transformation efficiencies of filamentous
fungi remain low compared to yeast [7]. To aid in this
process we developed a rapid screening protocol to detect
transformants containing transformed DNA. Colony-PCR
is a powerful approach because it is less laborious and
time-consuming than Southern analysis. For this proce-
dure to be efficient it is necessary to quickly obtain quality
template DNA for DNA amplification. Several methods
Southern blot analysis of two A. flavus transformants SOD#5 and SOD#30 after deletion of a putative superoxide gene (Gen- Bank No: CA747446) using an overlap PCR technique with pyr4 as a selectable marker Figure 8
Southern blot analysis of two A. flavus transformants SOD#5 and SOD#30 after deletion of a putative superox-
ide gene (GenBank No: CA747446) using an overlap PCR technique with pyr4 as a selectable marker. (A) 
Genomic DNA digested with Kpn I or BamH I and run on an 0.8% agrose gel. (B) Southern hybridization using N. crassa pyr4 as 
a probe amplified from plasmid pBSK-pyr4 with the following primer pairs: Pyr-F, 5' TTGGACCACACGAGTCAAG 3' and 
Pyr4-R, 5' GAAAACGAAATATCCTCCGCC 3'. Lanes 1 & 5 are SOD#5; Lanes 2 & 6 are SOD#30; Lanes 3 & 7 are 3357-5; 
Lane 4 is blank. Lanes 1–3 digested with Kpn I; Lanes 5–7 digested with BamH I. The two bands in lane 2 suggest multiple inte-
grations in SOD#30.BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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for isolation of DNA from conidia were examined with lit-
tle success. Fortunately, we were able to obtain high qual-
ity DNA from A. flavus conidia using the CTAB protocol,
which is routinely used to obtain DNA from plants. This
is a simple DNA extraction method for PCR-amplification
that worked extremely well regardless of the age of the
conidia.
The protocols for functional analysis described here make
the study of the aflatoxin biosynthetic pathway more
straightforward, and may possibly be extended to other
filamentous fungi.
Conclusion
The available genome sequence and whole genome DNA
microarrys for Aspergillus flavus make it a model system for
understanding pathogenicity and mycotoxin production
in a seed infecting fungus. To better understand the func-
tion of genes in this fungus it is necessary to have an effi-
cient system for gene replacement and complementation.
This study reports the use of the antibiotic phleomycin as
a dominant selectable marker for transformation and
overall improvements in both the transformation proto-
col and the selection of transformants of A. flavus. This
transformation protocol provides an efficient and power-
ful system for functional analysis in this fungus. Previous
transformation systems for this fungus rely on auxo-
trophic markers that require a mutation within the recipi-
ent strain. Using the phleomycin transformation protocol
no prior mutation is needed. Further, phleomycin can be
used in conjunction with other markers to readily disrupt
two genes in the same strain. This research will be of inter-
est to those working on pathogenicity and the molecular
biology of aflatoxin metabolism in A. flavus.
Methods
Strains and culture conditions
Aspergillus flavus 3357 obtained from the Fungal Genetics
Stock Center (University of Kansas, Kansas City, USA) and
A. flavus 3357-5 (pyrG, tox+) were used in this study. The
culture media used were PDA (Potato Dextrose Agar,
Difco), PDAU (PDA plus 1.12 g/l uracil), PDAUU (PDA
plus 1.12 g/l uracil and 1.2 g/l uradine), PDB (Potato Dex-
trose Broth, Difco), PDBU (PDB plus 1.12 g/l uracil), MM
(Czapeck-Dox Broth, Difco), MMU (MM plus 1.12 g/l
uracil), YPD (1% yeast extract, 2% peptone, 2% glucose,
and 1% agar), MLS (MM plus 0.4 M (NH4)2SO4 and 1%
agar). Fungi were grown on solid media at 30°C or shaken
in liquid culture at 200 rpm at 30°C when unless other-
wise mentioned.
Making pyrG mutant A. flavus 3357-5
A. flavus strain 3357-5 (pyrG, tox+) was produced from A.
flavus  3357 by chemical mutation as follows: 0.02 µl
NQO (4-nitroquinoline-N-oxide) stock solution (10 mg/
ml in acetone) was incubated with conidia (106) in 500 µl
of sterile 0.05% Triton X-100 in a microcentrifuge tube
and vortexed, followed by incubated at 30°C for 30 min.
The reaction was quenched by adding 500 µl of 5%
sodium thiosulfate. After vortexing, the mutagenized
conidia were incubated at room temperature for 5 min.
The conidia were then centrifuged at 1,000 rpm for 3 min,
resuspended in 1 ml of 0.05% Triton X-100, and centri-
fuged again. The final conidial pellet was resuspended in
500 µl of 0.05% Triton X-100. The mutagenized conidia
(105) were plated on MMU medium supplemented with
2 g/l of 5-fluoroorotic acid (FOA) and incubated at 30°C.
After 5–7 d, FOA resistant colonies were transferred using
toothpicks to MM and MMU simultaneously and incu-
bated at 30°C. After 2–3 d, those colonies which grew on
MMU but not on MM were transferred again to MM and
MMU simultaneously; this selection was repeated 3 times.
Finally, the stable FOA-resistant mutants were transferred
to MM, MM+FOA, MMU and MMU+FOA to test the abil-
ity to grow in the absence of uracil and the sensitivity to
FOA.
Aflatoxin measurement
AF production was observed using thin layer chromatog-
raphy (TLC) and high performance liquid chromatogra-
phy (HPLC). 108 conidia each of A. flavus 3357 and the
subsequent  pyrG  mutants were inoculated in 100 ml
PDBU and incubated at 30°C, 200 rpm for 30–36 h. For
TLC, AF was extracted and visualized on silica gel plates as
described by Hicks et al. [25]. HPLC analysis was per-
formed by the Mycotoxin Research Laboratory at NCSU
using culture media filtered through Whatman paper by
vacuum pump.
DNA constructs for transformation studies
pBSK-pyr4 and pBSK-pyrG were constructed by insertion
of the fragment carrying the uracil biosynthetic gene pyr4
from N. crassa or pyrG from A. nidulans into pBluescript
SK-. An overlap PCR construct (Figure 5) was constructed
according to Davidson et al. [18]. All primers used in con-
structing the overlap PCR construct are listed in Table 2
and shown in Figure 5. This construct contained a pyr4
gene, which replaced a putative superoxide dismutase
gene (GenBank accession no: CA747446) in A. flavus
genome, a gene homologous to sodM gene in A. oryzae
(GenBank accession no: AB078724) [26]. Plasmid pBC-
phleo, obtained from the Fungal Genetics Stock Center
[27], carries the phleomycin resistance cassette in which
the ble gene is under the control of the A. nidulans gpdA
promoter and the Saccharomyces cerevisiae CYC1 termina-
tor [17]. DNA was isolated using a Wizard Plus SV Mini-
preps Kit (Promega).BMC Microbiology 2007, 7:104 http://www.biomedcentral.com/1471-2180/7/104
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Preparation of protoplasts and transformation protocol
Conidia (109 per flask) were placed into 500-ml flasks
containing 100 ml PDBU and incubated at 30°C on a
rotary shaker at 200 rpm for 12–16 h. The cultures were
then centrifuged at 3,000 rpm for 10 min, washed with
sterile water and centrifuged again to completely remove
the growth medium. Enzyme solution was added to the
fungal tissue (15 ml enzyme solution per 5 g tissue was
added and contained 1.2 M NaCl, 10 mM NaPO3 (pH
7.0), 70 mg lysing enzyme (Sigma), 40 mg Driselase
(Sigma), 0.15 ml β-glucorinidase (98,000 u/ml, Sigma),
and 40 mg BSA). This mixture was then shaken at 70 rpm,
30°C for 3 h. Formation of protoplasts was monitored
microscopically.
Cell wall debris was removed by centrifugation at 750
rpm for 1 min. The supernatant was brought up to 50 ml
with STC buffer (1.2 M sorbitol, 10 mM Tris-HCl (pH
7.5), and 50 mM CaCl2). The protoplasts were then cen-
trifuged at 2,500 rpm for 5 min, washed with 50 ml of STC
buffer and centrifuged again. 300–500 µl STC buffer was
added to resuspend the protoplast pellet by gentle swirl-
ing. Protoplasts were then counted using a hemocytome-
ter and diluted to 108 protoplasts per ml.
100 µl aliquots of the diluted protoplasts were transferred
into 1.5 ml tubes and kept on ice. 1 µg of DNA to be trans-
formed was added to each tube and mixed by tapping.
One tube was used as a negative control (no DNA). After
incubation on ice for 20 min, 1 ml of a 50% PEG solution
(50 g PEG (Mr 3,350), 1 ml of 1 M Tris-HCl (pH 8), and 1
ml of 1 M CaCl2 in a final volume of 100 ml) was added,
mixed by tapping, and incubated at room temperature for
20 min. 100–300 µl of each transformation was plated on
the surface of regeneration MLS medium. The plates were
incubated at 37°C for 3–5 d.
Colony PCR analysis
The transformant colonies were transferred to duplicate
selection agar plates with toothpicks. Conidia of each fun-
gal colony were obtained from the surface of the agar
medium using 50 µl of 0.05% triton X-100 and placed
into a microcentrifuge tube containing some 0.5 mm glass
beads and 500 µl of CTAB buffer (2% CTAB, 100 mM Tris-
HCl (pH 8.0), 20 mM EDTA (pH 8.0), 1.4 M NaCl, 1%
polyvinylpyrrolidone-4000, 40 mM β-mercaptoethanol)
[28]. Samples were vortexed using a Disruptor Genie for 2
min. The samples were incubated at 65°C for 15 min,
then vortexed for 1 min, and incubated at 65°C for
another 15 min. 500 µl of chloroform : isoamyl alcohol
(24:1) was added and mixed well by shaking tubes. The
samples were then centrifuged for 5 min at maximum
speed. The aqueous phase was transferred into newly
labeled microcentrifuge tubes. 0.08 volumes of 7.5 M
NH4OAc and 0.54 volumes of isopropanol were added
and mixed well. The genomic DNA was pelleted by cen-
trifugation at maximum speed for 5 min. The DNA pellet
was resuspended in 20 µl of water.
5 µl of the DNA extracted from transformants or the recip-
ient strain was used as template for PCR-amplification.
The PCR primers used are shown in Table 2 and all PCR
reactions were in 50 µl. The PCR protocol used is as fol-
lows: denaturation at 94°C for 5 min; 30 cycles of 94°C
for 10 s, 55°C for 10 s, and 72°C for 1 min per kb of DNA;
72°C for 5 min. Products of the PCR were visualized on
agarose gel.
Southern blot analysis
Genomic DNA was isolated from cultures grown in PDB
or PDBU for 3 d using a DNeasy Plant Maxi Kit from Qia-
gen. DNA was further purified using a Wizard SV genomic
DNA purification column. For this procedure, five times
the volume of a solution containing 4.5 M guanidine thi-
ocyanate, 0.5 M potassium acetate was added to the
genomic DNA. This solution was passed through a SV
minicolumn and washed two times with wash buffer.
DNA was eluted with water. Approximately 2 µg of
genomic DNA was digested with either Kpn I or BamH I
(Promega) for approximately 6 h. Digested samples were
run on an 0.8% agarose gel at 90 V for 1 h. The gel was
treated and transferred to a Hybond-N+ nylon membrane
(Amersham pharmacia biotech) using standard proce-
dures. The membrane was allowed to dry slightly and then
Table 2: Primers used in this study
Primer name Sequence* Purpose**
P0 TTGAAGTCATGGTGGAGGTG 1
P1 ATGTACTCCGTACTCGGTTG 1, 2
P2 TTATATTCTCCCTCGCCATActtggaccacacgagtcaag 1, 2
P3 cttgactcgtgtggtccaagTATGGCGAGGGAGAATATAA 1, 2
P4 gcggaggatatttcgttttcATAACAAGGCCTCGTATGTG 1, 2
P5 CACATACGAGGCCTTGTTATgaaaacgaaatatcctccgc 1, 2
P6 ACTACACCTTGGGGACTGTA 1, 2
* Sequence in upper-case is homologous to A. flavus genome, and lower-case is homologous to pyr4 gene of N. crassa.
** Purpose 1: identifying transformants; purpose 2: constructing overlap PCR construct.Publish with BioMed Central    and   every 
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auto-cross linked (UV Stratalinker 1800, Stratgene). The
probe was prepared from pyr4 or ble using the DIG High
Prime DNA Labeling and Detection Starter Kit II from
Roche. Hybridization and washing was performed using
standard procedures. Detection was performed using the
chemiluminescent reagents supplied with the Kit fol-
lowed by autoradiography.
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